All Officials
Select methods...
Lobbying Records (Page 1 of 1)
2025-01-17
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Pauline Mulligan (Assistant Secretary), Department of Enterprise, Trade and Employment
Intent: To discuss with Minister Burke Amgen's current and future investments in Ireland and emerging public policy issues of interest
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Discussed Amgen's current and future investments in Ireland; discussed EU Pharma Legislation. |
2025-01-17
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment
Intent: Meet with Minister Burke to discuss EU pharmaceutical legislation, market access to innovative medicines, and Amgen's manufacturing footprint
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Discussed EU pharmaceutical legislation |
| — | market access to innovative medicines |
| — | and Amgen's manufacturing footprint in Ireland |
2025-01-17
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Max Murphy (Special Adviser), Department of the Taoiseach
Intent: Meet with the Taoiseach to discuss EU pharmaceutical legislation, IP, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Discussed EU pharmaceutical legislation |
| — | IP |
| — | market access to innovative medicines |
| — | and Amgen's manufacturing footprint in Ireland |
2025-01-17
Politician(s) lobbied: Billy Kelleher (MEP), European Parliament
Intent: Participate in hosted roundtable event
Methods: Event / Reception
Details & Methods:
| Method | Description |
|---|---|
| — | Discussed EU competitiveness for biopharmaceutical industry investments at ALDE 2024 party conference roundtable; discussed Biotech Act |
| — | EU Pharma Legislation |
| — | and Draghi Report. |
2025-01-17
Politician(s) lobbied: Seán Kelly (MEP), European Parliament
Intent: Discussion on importance of improving EU competitiveness
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Discussed regulation |
| — | need to keep EU competitive and support more clinical trials in Europe as part of AmCham EU delgation |
2025-01-17
Politician(s) lobbied: Billy Kelleher (MEP), European Parliament; Seán Kelly (MEP), European Parliament; Aodhán Ó Ríordáin (MEP), European Parliament
Intent: To secure a meeting to brief key MEPs on policy issues of importance to Amgen.
Methods: Letter
Details & Methods:
| Method | Description |
|---|---|
| — | Highlight importance of EU Biotech Act and finalization/implementation of EU Pharma Legislation |
| — | European Health Data Space |
| — | In Vitro Diagnostic Regulation and Clinical Trials Act as part of EU competitiveness. |
2025-01-17
Politician(s) lobbied: Nina Carberry (MEP), European Parliament; Barry Andrews (MEP), European Parliament; Regina Doherty (MEP), European Parliament; Billy Kelleher (MEP), European Parliament; Seán Kelly (MEP), European Parliament
Intent: Meetings to brief MEPs on key policy issues of importance to Amgen
Methods: Letter
Details & Methods:
| Method | Description |
|---|---|
| — | Requested meetings to discuss need to prioritize EU health policy and enhance EU competitiveness in biotech and life sciences in Ireland |
2024-09-18
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Chief of Staff), Department of the Taoiseach
Intent: To introduce the Taoiseach to the AmgenBiotech Experience and to discuss Amgen's ambitions in Ireland
Methods: Email
Details & Methods:
| Method | Description |
|---|---|
| — | Invitation for Taoiseach to attend Amgen Biotech Experience (ABE) event and meeting |
2024-09-18
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment
Intent: Provide an introduction to Amgen and to discuss policy priorities to enhance Ireland’sreputation as a global leader in foreign direct investment and in the life sciences industry
Methods: Email
Details & Methods:
| Method | Description |
|---|---|
| — | Request for meeting with Minister Burke regarding life sciences policy |